Cochlear Ltd Revises FY26 Earnings Forecast Amid Market Challenges
Cochlear Ltd has updated its trading performance, reducing its FY26 earnings guidance to A$290-330 million. The company anticipates a 2-6% sales growth in the second half, in constant currency. Challenges in developed markets and Middle Eastern conflict have influenced these adjustments and potential receivables provisioning.
In a recent trading update, Cochlear Ltd announced a downward revision of its FY26 earnings guidance, now projected between A$290-330 million. The adjustment comes amidst softened trading conditions for Cochlear implants in developed markets, prompting the company to reshape its cost base to create more growth opportunities.
Despite challenges, Cochlear Ltd expects a modest sales growth of 2-6% in the second half, measured in constant currency. The Middle Eastern conflict adds further uncertainty to Q4 sales forecasts, potentially impacting receivables by up to A$10 million.
Cochlear Ltd's strategic focus remains on restructuring operations to navigate the shifting market landscape while sustaining long-term growth initiatives. Stakeholders will be closely monitoring how these adjustments and external factors play out in the company’s overall performance.